Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
Eur J Endocrinol. 2012 Mar;166(3):537-42. doi: 10.1530/EJE-11-0494. Epub 2011 Dec 14.
The association in young females of long-standing primary hypothyroidism, isosexual precocious pseudopuberty and multicystic enlarged ovaries was first described in 1960 by Van Wyk and Grumbach. Since then, sporadic case reports have contributed to clarifying the key features of this syndrome. The unique elements that lead to this diagnosis are FSH-dominated sexual precocity combined with a delayed bone age in the presence of hypothyroidism. It is important to recognise this syndrome because initiating simple thyroid hormone replacement completely resolves symptoms and hormone abnormalities, avoiding unnecessary investigations for malignancies or surgical intervention. We describe an 8-year-old girl with autoimmune thyroiditis and severe long-standing hypothyroidism presenting with the clinical features of Van Wyk-Grumbach syndrome, a secondary TSH-secreting adenoma and hyperprolactinaemia. In addition, this girl presented with microcytic anaemia, elevated erythrocyte sedimentation rate (ESR) and two unusual features - a newly developed streaky hyperpigmented skin lesion and parathyroid hormone suppression despite vitamin D deficiency. Thyroxine replacement normalised all hormone abnormalities and shrunk the pituitary adenoma within 9 months, but the new skin lesion persisted. We review the literature and explore the pathophysiology of known and new features that give rise to speculation indicating stimulation of the FSH G protein-coupled receptor by excessive TSH, but LH suppression by hyperprolactinaemia.
1960 年,Van Wyk 和 Grumbach 首次描述了年轻女性中存在的长期原发性甲状腺功能减退症、同性性早熟假性性早熟和多囊性增大卵巢之间的关联。从那时起,零星的病例报告有助于阐明该综合征的关键特征。导致这种诊断的独特因素是 FSH 主导的性早熟,同时伴有甲状腺功能减退症时的骨龄延迟。认识到这种综合征很重要,因为简单的甲状腺激素替代治疗可以完全解决症状和激素异常,避免对恶性肿瘤或手术干预进行不必要的检查。我们描述了一位 8 岁女孩,患有自身免疫性甲状腺炎和严重的长期甲状腺功能减退症,表现为 Van Wyk-Grumbach 综合征的临床特征,即继发性 TSH 分泌性腺瘤和高催乳素血症。此外,该女孩还出现了小细胞性贫血、红细胞沉降率升高(ESR)以及两个不寻常的特征——新出现的条纹状色素沉着皮肤病变和甲状旁腺激素抑制,尽管存在维生素 D 缺乏症。甲状腺素替代治疗使所有激素异常正常化,并在 9 个月内使垂体腺瘤缩小,但新的皮肤病变仍存在。我们回顾了文献,并探讨了已知和新特征的病理生理学,这些特征表明 FSH G 蛋白偶联受体受到过度 TSH 的刺激,但 LH 受到高催乳素血症的抑制。